invent Diagnostica

Executive Summary

invent Diagnostica GmbH is a German in vitro diagnostics (IVD) company founded in 1990, specializing in the sourcing, development, and production of ethically derived human biospecimens, control materials, and custom services for diagnostic manufacturers. The company's portfolio includes high-quality blood products, tissues, and specialty samples essential for assay validation, quality control, and research. By serving as a reliable partner to IVD firms, invent Diagnostica plays a critical role in ensuring the accuracy and reliability of diagnostic tests used in clinical laboratories worldwide. As the global IVD market grows, driven by increasing demand for personalized medicine and point-of-care testing, invent Diagnostica is well-positioned to expand its offerings. The company's expertise in rare and disease-specific biospecimens addresses the need for more representative controls in emerging diagnostic areas such as liquid biopsy and companion diagnostics. While remaining privately held, invent Diagnostica has potential to capture additional market share through portfolio expansion and strategic collaborations. However, limited public information constrains visibility into near-term growth trajectories.

Upcoming Catalysts (preview)

• Q1 2027Expansion of Biospecimen Portfolio into Oncology and Rare Diseases70% success
• Q4 2026IVDR Certification for Key Control Products80% success
• H2 2027Strategic Partnership with a Major IVD Manufacturer50% success